Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 44, 2015 - Issue 8: Immunotherapy
436
Views
0
CrossRef citations to date
0
Altmetric
Letter from the Editor

Letter from the Editor

References

  • Amsterdam D. (2015). Immunotherapeutic approaches for the control and eradication of HIV. Immunol Invest, 44, 719–30
  • Brandtzaeg P. (2010). Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest, 39, 303–55
  • Chodon T, Koya RC, Odunsi K. (2015). Active immunotherapy of cancer. Immunol Invest, 44, 817–36
  • Datta K, Hamad, M. (2015). Immunotherapy of fungal infections. Immunol Invest, 44, 738–76
  • de Azevedo MT, Saad ST, Gilli SC. (2013). IL4 and IFNalpha generation of dendritic cells reveals great migratory potential and NFkB and cJun expression in IL4DCs. Immunol Inves, 42, 711–25
  • Dziak R. (2013). The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells. Immunol Invest, 42, 510–8
  • Erfani N, Khademi B, Haghshenas MR, et al. (2012). Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. Immunol Invest, 42, 81–90
  • Feng H, Fan J, Du X, et al. (2015). Sulfated radix Cyathulae officinalis polysaccharides act as adjuvant via promoting the dendritic cell maturation and suppressing Treg Frequency. Immunol Invest, 44, 288–308
  • Habibagahi M, Razmkhah M, Niri NM, et al. (2013). Combined 4-1BB and CD28 costimulation could unleash lymphocytes from immunosuppression induced by adipose derived stem cell soluble products. Immunol Invest, 42, 307–23
  • Haile LA, Greten TF, Korangy F. (2012). Immune suppression: The hallmark of myeloid derived suppressor cells. Immunol Invest, 41, 581–94
  • Hilchey SP, Bernstein SH. (2007). Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies. Immunol Invest, 36, 629–48
  • Huemer HP, Geiger M, Posch W, et al. (2013). Protein kinase c overexpression does not enhance immune-stimulatory surface markers of vaccinia-infected dendritic cells and DC cell lines. Immunol Invest, 42, 164–77
  • Inn KS, Lee GJ, Quan FS. (2014). A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice. Immunol Invest, 43, 236–54
  • Johnson TS, Munn DH. (2012). Host indoleamine 2,3-dioxygenase: Contribution to systemic acquired tumor tolerance. Immunol Invest, 41, 765–97
  • Jung M, Park PT, Park JH, et al. (2014). Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge. Immunol Invest, 44, 101–12
  • Kim SJ, Ha GH, Kim SH, Kang CD. (2014). Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells. Immunol Invest, 43, 517–34
  • Li L, Shi X, Lu Q, et al. (2012). Role of human CD4 D1D2 domain in HIV-1 infection. Immunol Invest, 42, 106–21
  • Liao Y, Geng P, Tian Y, et al. (2014). Marked anti-tumor effects of CD8+CD62L+ T cells from melanoma-bearing mice. Immunol Invest, 44, 147–63
  • Long J, Zhou B, Li H, et al. (2013). Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide. Immunol Invest, 42, 137–55
  • Lu J, Sun T, Wang D, et al. (2015). Protective immune responses elicited by fusion protein containing PsaA and PspA fragments. Immunol Invest, 44, 482–96
  • Manohar A, Ahuja J, Crane JK. (2015). Immunotherapy for infectious diseases: Past, present, and future. Immunol Invest, 44, 731–7
  • Mastrandrea D. (2015). An overview of organ-specific autoimmune diseases including immunotherapy. Immunol Invest, 44, 803–16
  • Mosaad YM. (2014). Immunology of hematopoietic stem cell transplant. Immunol Invest, 43, 858–87
  • Obermajer N, Wong JL, Edwards RP, et al. (2012). PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunol Invest, 41, 635–57
  • Ostrov, E. (2015). Immunotherapeutic biologic agents in autoimmune and autoinflammatory diseases. Immunol Invest, 44, 777–802
  • Pesmatzoglou M, Dimitriou H, Stiakaki E. (2013). Could mesenchymal stromal cells have a role in childhood autoimmune diseases? Immunol Invest, 42, 639–56
  • Samasca G, Sur G, Lupan I. (2013). Current trends and investigative developments in celiac disease. Immunol Invest, 42, 273–84
  • Shahabi S, Azizi H, Mazloomi E, et al. (2014). A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei. Immunol Invest, 43, 653–66
  • Son CH, Bae JH, Shin DY, et al. (2013). Enhanced maturation and function of dendritic cells using hydrogel coated plate and antigen electroporation. Immunol Invest, 42, 341–55
  • Son CH, Bae JH, Shin DY, et al. (2014). Antitumor effect of dendritic cell loaded ex vivo and in vivo with tumor-associated antigens in lung cancer model. Immunol Invest, 43, 447–62
  • Song SS, Yuan PF, Li PP, et al. (2015). Protective effects of total glucosides of paeony on N-nitrosodiethylamine-induced hepatocellular carcinoma in rats via down-regulation of regulatory B cells. Immunol Invest, 44, 521–35
  • Souza PP, Lerner UH. (2013). The role of cytokines in inflammatory bone loss. Immunol Invest, 42, 555–622
  • Tabatabaeizadeh SE, Bassami MR, Haghparast A, Dehghani H. (2015). Employing XIAP to enhance the duration of antigen expression and immunity against an avian influenza H5 DNA vaccine. Immunol Invest, 44, 199–215
  • Xu L, Bao L, Li F, et al. (2013). Intranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5. Immunol Invest, 43, 224–35
  • Zheng MC, Xing H. Xiao N, et al. (2014). Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis. Immunol Invest, 43, 705–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.